OFIX News and Press, Orthofix Medical Inc. From 03/16/22

Medical device company, Orthofix Medical (OFIX +0.1%), announced on Monday that the U.S. Food and Drug Administration (FDA) issued 510(k) clearance for its TrueLok EVO Ring Fixation System. TrueLok EVO is a circular fixator designed for limb reconstruction and deformity correction procedures,...

Designed for complex limb reconstruction and deformity correction procedures, the system features radiolucent rings and struts for clearer visualization under X-ray Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, ...

The shares of medical device and biologics company, Orthofix Medical (OFIX +7.4%), has risen sharply after Stifel upgraded it to Buy from Hold, citing the prospects in growth and margins. The price target raised to $45 from $41 per share implies a premium of ~34% to the last close. When the f...

Orthofix Medical Inc. (OFIX) Q4 2021 Results Conference Call February 25, 2022 08:30 AM ET Company Participants Alexa Huerta - Senior Director of Investor Relations Jon Serbousek - President & Chief Executive Officer Doug Rice - Chief Financial Officer Conference Call Participants Mathew ...

Orthofix press release (NASDAQ:OFIX): Q4 Non-GAAP EPS of $0.27 beats by $0.10. Revenue of $125.06M (+6.3% Y/Y) beats by $0.23M. FY22 outlook: The company expects revenue to be in the range of $475M- S490M vs consensus of $489.03M; Adj. EPS expected to be $0.58-$0.73 vs consensus of $0.82 Fo...

Fourth quarter net sales of $125.1 million, an increase of 6% over the prior year 2021 annual net sales of $464.5 million, an increase of 14% over the prior year Double-digit net sales growth in the quarter and for the year compared to the prior year period...

Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the full market launch of Opus ™ BA, a synthetic bioactive bone graft solution for cervical and lumbar spine fusion procedures. This press release...

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that it plans to release financial results for the fourth quarter and full year 2021 before market open on Friday, February 25, 2022. Jon Serbousek, President and Chi...

Because record-high inflation and expected interest rate hikes are roiling the equity markets, it could be wise to buy MedTech stocks due to the industry's solid growth prospects and a near-inelastic demand for MedTech products with rising health awareness. So, we believe quality MedTech comp...

Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, and nView medical, a Salt Lake City-based company developing surgical imaging and guidance systems enabled by artificial intelligence (AI), today announced a partnership and inv...